Large-scale testing (Phase 3)Study completedNCT00138944
What this trial is testing
Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension
Who this might be right for
Essential Hypertension
University of Erlangen-Nürnberg Medical School 85